Are we ready for targeted therapy combinations in HCC?

Einat Cinnamon; Eli Pikarsky

doi:10.1136/gutjnl-2019-319780

Are we ready for targeted therapy combinations in HCC?

Einat Cinnamon, Eli Pikarsky

Department of Immunology and Cancer Research

The Hebrew University of Jerusalem

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	613-614
Number of pages	2
Journal	Gut
Volume	69
Issue number	4
DOIs	https://doi.org/10.1136/gutjnl-2019-319780
State	Published - 1 Apr 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

hepatocellular carcinoma

All Science Journal Classification (ASJC) codes

Gastroenterology

Access to Document

10.1136/gutjnl-2019-319780

Cite this

@article{dce8518293dc4f0eb200c04f083aebe5,

title = "Are we ready for targeted therapy combinations in HCC?",

keywords = "hepatocellular carcinoma",

author = "Einat Cinnamon and Eli Pikarsky",

note = "Funding Information: together written the paper. Funding This study was funded by the Israel Science Foundation and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.",

year = "2020",

month = apr,

day = "1",

doi = "10.1136/gutjnl-2019-319780",

language = "الإنجليزيّة",

volume = "69",

pages = "613--614",

journal = "Gut",

issn = "0017-5749",